AVTR · Avantor Inc

15.19−0.33  (−2.13%)

Price

Snapshot

50 fields · last close
Market Cap$10.50B
P/E
Float650.7M
Beta0.97
Volatility24.3%
ExchangeNYSE
SectorLife Sciences Tools & Services
Cap tierLarge cap
Macro sensitivityModerate
Clavix score69
Price15.19
Change−2.13%
Prev Close15.52
Open15.87
Day Low15.44
Day High15.90
Avg Vol9
Avg $ Vol$146.3M
52W High16.05
52W Low7.26
52W Pos90.2%
From High−5.36%
From Low+109.08%
Max DD 1Y−52.50%
Spread0.10%
LiquidityNormal
SMA 20+2.02%
SMA 50+12.25%
SMA 200+44.15%
RSI (14)64.9
Vol 30D29.1%
Vol 90D47.7%
1Y Range7–16
Daily bars900
Perf Week+4.79%
Perf Month+11.17%
Perf Quarter+62.00%
Perf Half Y+103.94%
Perf Year+25.16%
Perf YTD+32.55%
Prev Day−2.13%
ClavixB-
Debt / Eq0.71
Curr Ratio1.78
Int Cover-1.8×
FCF Margin6.8%
Rev Growth+0.5%
ProfitUnprofitable
LeverageModerate
Sector rank15 / 19

Clavix risk grade

regraded every trading day
B-69/100

AVTR grades B-, 69 of 100. Steadiest on Sector Resilience (68), most exposed on Price Stability (51, mixed). 1 of the 4 weighted dimensions sit above the Life Sciences Tools & Services median. Ranks 15 of 19 in Life Sciences Tools & Services by Clavix score.

PriceMacroSectorNewsFinancial

How rough the ride is

AVTRLife Sciences Tools & Services median
Betavs the overall market · lower is steadier0.971.18
Volatilityannualized24.3%29.6%
Max drawdown, past yearworst peak-to-trough fall−52.5%
Typical daily movemedian absolute daily change1.49%
Days beyond ±3%of the last 252 sessions5823%

How its days are spread

Daily returns over the last 252 sessions in 1% bins. Moves beyond ±6% land in the end bins.

52-week range

AVTR
15.52

The bar runs from the lowest to the highest close of the last 252 sessions; the marker is the latest close.

Drawdown from the 1-year peak

AVTR

Percent below the running high over the last 12 months. Zero is a fresh high.

Market sensitivity

AVTRLife Sciences Tools & Services median
Beta to the markethow much it swings with the S&P 500 · lower is safer0.971.18
Macro sensitivityrate, dollar and credit exposure bucketModerateModerate47% of 19

Where it sits on the macro scale

Low 1Moderate 9High 6Very High 3

Low means rates, the dollar and credit spreads barely move it. Very High means they drive a large share of its swings. The counts are how many Life Sciences Tools & Services names sit in each bucket.

Where it ranks in its sector

Sector
Life Sciences Tools & Services19 companies ranked
AVTR
#15 of 19

Rank by Clavix score within the sector. Right is the top of the sector.

Price performance

AVTR
1 week+4.8%
1 month+11.2%
Year to date+32.5%
1 year+25.2%

Context for the rank, not itself a risk measure.

Recent coverage, scored

AVTR
Articles scoredthe most recent scored coverage, up to 3030since 26 Jul
Average score0 most bearish, 100 most bullish66
Bullish · bearisharticles above 60 · below 4020 · 2
Directionarticles whose tone is improving vs worsening20 ↑ 2 ↓

Where the article scores land

Each bar is a 10-point band of article scores. Below 40 reads bearish, above 60 bullish.

Balance sheet, against the sector

Debt / equityTotal debt vs shareholder equity · lower is stronger
0.71sector median 0.51 · 19 names
Current ratioShort-term assets vs liabilities · higher is stronger
1.78sector median 1.89 · 19 names
FCF marginFree cash flow as a share of revenue · higher is stronger
6.8%sector median 18.6% · 18 names
Interest coverageOperating income vs interest expense · higher is stronger
-1.8×sector median 3.5× · 19 names

The shaded band is the middle half of the 19 Life Sciences Tools & Services names Clavix covers; the tick is the sector median.

Growth

AVTR
Revenue growthyear over year+0.5%

Financial Health is shown but does not count toward the grade. Why

0–100, higher is safer. The tick on each bar is the Life Sciences Tools & Services median. Click a dimension for the evidence behind it. Financial Health is shown but does not count toward the grade.

Recent news

most recent scored articles · the chip is the article’s score · click to open

Avantor appointed Todd Garner as Executive Vice President and Chief Financial Officer, effective September 21, 2026. Garner previously served as EVP and CFO of CONMED Corporation from 2018 to 2026 and brings over 30 years of finance and operational leadership experience, including prior roles at C. R. Bard.

Source sec.gov Significance major Impact leadership Risk improving

Read the article →

Avantor announced on September 17, 2026 that it has appointed Todd Garner as Executive Vice President and Chief Financial Officer, effective September 21, 2026. Garner, age 57, previously served as CFO of medical technology company CONMED Corporation from January 2018 to March 2026 and held several finance roles at C.R. Bard from 2003 to 2017.

Source sec.gov Significance major Impact leadership Risk neutral

Read the article →

Avantor is expanding its line of single-use bioprocessing products (disposable bags, tubing, and similar items used by drug manufacturers) called RIM across the Asia-Pacific region, making locally produced versions more available to customers there.

Source Zacks Investment Research Significance minor Impact product Risk improving

Read the article →

Avantor (AVTR) is expanding its RIM line of single-use bioprocessing products across the Asia-Pacific region, increasing access to locally manufactured versions of these items. Single-use bioprocessing refers to disposable equipment used in making biologic drugs and vaccines.

Source yahoo.com Significance minor Impact product Risk improving

Read the article →

An article argues for adding Avantor stock, citing strong second-quarter results, improving orders, and a raised full-year 2026 outlook, while flagging weakness in the BMP business segment and uneven demand as ongoing concerns.

Source Zacks Investment Research Significance moderate Impact financial impact Risk improving

Read the article →

Nearest peers by size

Life Sciences Tools & Services
TickerCompanyGradeMkt capP/EBeta
RGENRepligen CorpB-$9.98B240.331.14Compare
TXG10X Genomics IncC-$9.98B2.04Compare
TECHBio-Techne CorpB$11.35B62.401.30Compare
BRKRBruker CorpC$9.35B1.25Compare
QGENQiagen NVB+$8.93B21.820.60Compare
CRLCharles River Laboratories International IncB-$13.27B1.41Compare
TEMTempus AI IncD-$14.05B2.33Compare
RVTYRevvity IncB$16.01B67.381.09Compare

You just read one holding. Clavix reads the whole portfolio.

Every position you own, graded on the same five dimensions, with an alert when a grade moves. Three months free on iPhone.